Publikationen im NUM

Schlickeiser S, Schwarz T, Steiner S, Wittke K, Al Besher N, Meyer O, Kalus U, Pruß A, Kurth F, Zoller T, others . Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2021; 11628971.      [DOI] 

Heinrich F, Romich C, Zimmermann T, Kniep I, Fitzek A, Steurer S, Glatzel M, Nörz D, Günther T, Czech-Sioli M, Fischer N, Grundhoff A, Lütgehetmann M, Ondruschka B. Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant. Int J Legal Med. 2021; 1-10.      [DOI] 

Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt ea. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife. 2021; 10

Gieselmann L, et al . Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nature Protocols. 2021;      [DOI] 

Deckert A, Anders S, Allegri M, et al . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials. 2021; 22(1):      [DOI] 

Deckert A, Anders S, Allegri M, others . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials. 2021; 22(1):      [DOI]      [Datei] 

Deckert A, Anders S, De Allegri M, et al . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials. 2021; 22(1):      [DOI] 

Deckert A, Anders S, Allegri M, others . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials. 2021; 22(1):      [DOI]      [Datei] 

Beschoner P, Jarczok M, Kempf M, Weimer K, Geiser F, Hiebel N, Erim Y, Morawa E, Steudte-Schmiedgen S, Albus C, Jerg-Bretzke L. egePan-VOICE study on the psychosocial burden of the Covid-19 pandemic among medical technical assistants. Z Psychosom Med Psychother. 2021;

Kahn M, Zellmer S, Ebigbo A, et al . Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol. 2021; 59(12):      [DOI] 

Zellmer S, Kahn M, Ebigbo A, et al . Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol. 2021; 59(8):      [DOI] 

Jensen B, Luebke N, Feldt T, et al . Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021; 8      [DOI] 

Jensen B, Luebke N, Feldt T, Keitel V, Brandenburger T, Kindgen-Milles D, Lutterbeck M, Freise NF, Schoeler D, Haas R, Dilthey A, Adams O, Walker A, Timm J, Luedde T. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. The Lancet regional health. Europe. 2021; 8100164.      [DOI] 

Ruhl L, et al . Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal transduction and targeted therapy. 2021; 6418.      [DOI] 

Stillfried S, Boor P, PANDEMIcs D. Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin. Pathologe. 2021; 1-5.      [DOI] 

Zack F, Nigbur S, Manhart J, Derani H, Boy D, Kolbe V, Büttner A. Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock. Ärztebl Meckl-Vorpom. 2021; 31125-128.

Revet A, Hebebrand J, Anagnostopoulos D, Kehoe L, Child C, Bender S, Klauser P. ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services. European Child & Adolescent Psychiatry. 2021;      [DOI] 

Wagner R, Peterhoff D, Beileke S, et al . Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: The population-based Tirschenreuth study in the hardest-hit German county in spring 2020. Viruses. 2021; 13(6):      [DOI]      [Datei] 

Jones TC, et al . Estimating infectiousness throughout SARS-CoV-2 infection course. Science (New York, N.Y.). 2021;      [DOI] 

Eberhardt KA, et al . Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021; 9      [DOI] 

Korenkov M, Poopalasingam N, Madler M, et al . Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals. J Clin Microbiol. 2021; 59(9):      [DOI] 

Toptana T, Eckermann L, Pfeiffer AE, et al . Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?. J Clin Virol. 2021; 135      [DOI] 

Metzendorf M, Featherstone RM. Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production. Res Synth Methods. 2021 Jun.;      [DOI] 

Hildebrandt J, Metzendorf MI, Jakob T. Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister. GMS Med Inform Biom Epidemiol. 2021; 17(3):Doc12.      [DOI]      [Datei] 

Popp M, Kranke P, Meybohm P, Metzendorf M, Skoetz N, Stegemann MS, Weibel S. Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges. BMJ Evid Based Med. 2021; 2021bmjebm-2021-111791.      [DOI] 

Wachinger J, Schirmer M, Täuber N, et al . Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study. BMJ Paediatr Open. 2021; 5(1):      [DOI]      [Datei] 

Tielker JM, Weber JP, Simon ST, Bausewein C, Stiel S, Schneider N. Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLoS ONE. 2021; 16(7):e0254056.      [DOI] 

Muenchhoff M, Graf A, Krebs S, et al . Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Euro Surveill. 2021; 26(43):      [DOI]      [Datei] 

Thun S, Sass J, Bartschke A. German Corona Consensus Datensatz (GECCO): Verbesserter Austausch von COVID-19-Forschungsdaten. kma - Klinik Management aktuell. 2021; 26(06):55—56.      [DOI] 

Gruber A, Firsching T, Trimpert J, Dietert K. Hamster models of COVID-19 pneumonia reviewed: How human can they be?. Vet Pathol. 2021;

Schmidt M, Kugai S, Amarell N, Weltermann B. Handlungsfähigkeit von Hausärzt*innen während der COVID-19-Pandemie. DocV-15-05. 2021;      [DOI] 

Klein JAF, Krüger LJ, Tobian F, et al . Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med Microbiol Immunol. 2021; 210(4):      [DOI]      [Datei] 

Hadzibegovic S, Lena A, Churchill T, Ho J, Potthoff S, Denecke C, Rösnick L, Heim K, Kleinschmidt M, Sander L, others . Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail. 2021; 23(11):1891—1902.      [DOI] 

Groß R, et al . Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants. EBioMedicine. 2021; 75103761.      [DOI] 

Tenbusch M, Schumacher S, Vogel E, et al . Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. Lancet Infect Dis. 2021; 21(9):      [DOI] 

Rössler M, Jacob J, Risch L, Tesch F, Enders D, Wende D, Jucknewitz R, Weidinger O, Batram M, Ballesteros P, Baßler S, Hertle D, Repschläger U, Richter N, Schulte C, Schramm A, Sobik F, Treskova-Schwarzbach M, Scholz S, Walker J, others . Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen. 2021;      [DOI] 

Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke ea. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells. Mucosal Immunol. 2021; 141381—1392.

Lehmann M, Allers K, Heldt C, et al . Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunol. 2021; 1-12.      [DOI] 

Barros-Martins J, Hammerschmidt SI, Cossmann A. Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. MedRxiv. 2021;      [DOI]      [Datei] 

Trump S, Lukassen S, Anker SM, Chua RL, Liebig J, Thurmann ea. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021; 39705—716.      [DOI] 

Walsh C, Tafforeau P, Wagner W, et al . Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods. 2021; 18(12):1532-1541.      [DOI] 

Barros-Martins J, et al . Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nature Medicine. 2021; 271525—1529.      [DOI] 

Burnett DL, et al . Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability. Immunity. 2021; 542908—2921.e6.      [DOI] 

Schrezenmeier E, et al . Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis. Frontiers in immunology. 2021; 12690698.      [DOI] 

Ahrens KF, Neumann RJ, Kollmann B, Brokelmann J, Werthern NM, Malsyhau A, Weichert D, Lutz B, Fiebach CJ, Wessa M, others . Impact of COVID-19 lockdown on mental health in Germany: Longitudinal observation of different mental health trajectories and protective factors. Translational Psychiatry. 2021; 11(1):1—10.      [DOI] 

Mühlemann B, et al . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;      [DOI] 

Mühlemann B, Thibeault C, Hillus D, Helbig E, Lippert L, Tober-Lau P, Schwarz T, Müller M, group P, Witzenrath M, others . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021;      [DOI] 

Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch A, Kasten M, Zapatero-Belinchón F, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand J, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan G, Höfer A, Kühnel M, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer T, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021 Aug.; 16(8):e0255335.      [DOI] 

Dauletbaev N, Kuhn S, Holtz S, Waldmann S, Niekrenz L, Müller BS, Bellinghausen C, Dreher M, Rohde GGU, Vogelmeier C. Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol. BMJ Open. 2021; 11(9):e053819.      [DOI] 

Müller A, Melzow FS, Göstemeyer G, Paris S, Schwendicke F. Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers. International Journal of Environmental Research and Public Health. 2021; 18(11):5710.      [DOI]